Why Patient Engagement Is Essential for Market Access of Medical Innovation in Belgium
In recent years, it has become increasingly clear that medical innovation is not only a technical or economic issue. It is also a social and ethical one. New treatments, ranging from well-known drugs to advanced therapies such as ATMPs, are reshaping expectations for patients and healthcare providers. Yet these innovations continue to face complex market […]
Faster Access to Innovative Medicines in the BeNeLux
Innovative medicines are evolving one after another at an accelerating pace, yet for patients, access can still feel slow and unequal. Across the BeNeLux countries, different systems exist to bridge this gap, each with its own logic, rules, and pitfalls. In this blog, we take you through Belgium, the Netherlands, and Luxembourg, and explain how […]